RussellPSanetoDO

Child Neurology • Seattle, WA

Pediatric neurology at Seattle Children's

Join to view full profile

Dr. Saneto is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Saneto's full profile

Already have an account?

Office
4800 Sand Point Way NE
Seattle, WA 98105
Phone+1 206-987-2000

Education & Training

Cleveland Clinic FoundationFellowship, Clinical Neurophysiology, 2000 - 2001
Cleveland Clinic FoundationFellowship, Child Neurology, 1997 - 1998
Cleveland Clinic FoundationResidency, Pediatrics, 1994 - 1997
Des Moines University College of Osteopathic MedicineClass of 1994

Certifications & Licensure

OH State License 1995 - 2026
ID State License 2023 - 2025
MT State License 2023 - 2025
OR State License 2021 - 2025
WA State License 2001 - 2025
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
American Board of Psychiatry and Neurology Epilepsy

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) Start of enrollment: 2010 Dec 01
Recruiting
Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) Start of enrollment: 2014 Feb 28
Completed
Phase 2
Alpers Huttenlocher Natural History Study Start of enrollment: 2014 Jan 01
Terminated
A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome Start of enrollment: 2021 Nov 08
Completed
Phase 3
Roles: Principal Investigator
A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome Start of enrollment: 2022 Mar 04
Recruiting
Phase 3
Roles: Principal Investigator
Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency: Start of enrollment: 2020 Jul 14
Active, not recruiting
Phase 3
Roles: Contact
A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome Start of enrollment: 2021 Oct 28
Completed
Phase 3
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable Mitochondrial DNA Depletion/Deletions Disease.
Agustin Hidalgo-Gutierrez, Jonathan Shintaku, Javier Ramon, Eliana Barriocanal-Casado, Alba Pesini
Annals of Neurology. 2024-12-01
Using a Previsit Questionnaire for Initial Visits in a Pediatric Mitochondrial Clinic: Perspectives of Parents, a Specialty Physician, and a Clinical Coordinator.
Coral J Sepulveda, Elaine Walsh, Kristen Carlin, Russell P Saneto
Journal of Child Neurology. 2024-11-01
2 citations
Mitochondria transfer-based therapies reduce the morbidity and mortality of Leigh syndrome.
Ritsuko Nakai, Stella Varnum, Rachael L Field, Henyun Shi, Rocky Giwa
Nature Metabolism. 2024-10-01

Journal Articles

Case Report Epileptic Spasms as the Presenting Seizure Type in a Patient with a New “O” of TORCH, Congenital Zika Virus Infection
Jason Lockrow, Russell P Saneto, ScienceDirect
Why West? Comparisons of Clinical, Genetic and Molecular Features of Infants with and Without Spasms
Jason Coryell, Joseph E Sullivan, William B Dobyns, John R Mytinger, Annapurna Poduri, Nicole Ryan, Tobias Loddenkemper, Courtney Wusthoff, Elaine C Wirrell, Kelly G K..., PLoS One

Press Mentions

An Indian Couple's Fight to Save Their Son from a Rare Genetic Disorder – You Can HelpOctober 8th, 2019
Marijuana-Derived Cannabidiol Drug Reduces Seizures from Epilepsy in StudyDecember 23rd, 2015